+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bleeding Disorders Treatment Market Research Report by Drug Class, by Disease Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989638
  • Report
  • July 2021
  • Region: Global
  • 192 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Bleeding Disorders Treatment Market will Grow to USD 17.67 Billion by 2026, at a CAGR of 9.09%

FEATURED COMPANIES

  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Xenetic Biosciences, Inc.
The Global Bleeding Disorders Treatment Market size was estimated at USD 10.48 Billion in 2020 and expected to reach USD 11.39 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 9.09% to reach USD 17.67 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Bleeding Disorders Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Class, the Bleeding Disorders Treatment Market was studied across Antibrinolytics, Desmopressin, Fibrin Sealant, Plasma Derived Coagulation Factor Concentrates, and Recombinant Coagulation Factor Concentrates.
  • Based on Distribution Channel, the Bleeding Disorders Treatment Market was studied across Compounding Pharmacies, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Disease Type, the Bleeding Disorders Treatment Market was studied across Hemophilia A, Hemophilia B, and Von Willebrand Disease.
  • Based on Region, the Bleeding Disorders Treatment Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bleeding Disorders Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bleeding Disorders Treatment Market, including Alnylam Pharmaceuticals Inc., Amgen Inc., Baxter International Inc., Bayer AG, Bristol-Myers Squibb Company, Compounding Pharmacies Bioverativ Inc., Janssen Global Services, LLC, Pfizer Inc., Sanofi S.A., and Xenetic Biosciences, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Bleeding Disorders Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bleeding Disorders Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bleeding Disorders Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Bleeding Disorders Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Bleeding Disorders Treatment Market?
6. What is the market share of the leading vendors in the Global Bleeding Disorders Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Bleeding Disorders Treatment Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Xenetic Biosciences, Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Distribution Channel Outlook
3.5. Disease Type Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of liver disorders and anemia
5.1.1.2. Rising healthcare expenditure by the government of developing countries
5.1.2. Restraints
5.1.2.1. Lack of skilled professionals and trained expertise
5.1.2.2. Lack of favourable reimbursement policies
5.1.3. Opportunities
5.1.3.1. Rising awareness regarding bleeding disorders
5.1.3.2. Rise in demand due to lower infection risks and high investments in research and development
5.1.4. Challenges
5.1.4.1. High cost of medications of bleeding disorders treatment
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Bleeding Disorders Treatment Market, by Drug Class
6.1. Introduction
6.2. Antibrinolytics
6.3. Desmopressin
6.4. Fibrin Sealant
6.5. Plasma Derived Coagulation Factor Concentrates
6.6. Recombinant Coagulation Factor Concentrates

7. Bleeding Disorders Treatment Market, by Distribution Channel
7.1. Introduction
7.2. Compounding Pharmacies
7.3. Hospital Pharmacies
7.4. Retail Pharmacies

8. Bleeding Disorders Treatment Market, by Disease Type
8.1. Introduction
8.2. Hemophilia A
8.3. Hemophilia B
8.4. Von Willebrand Disease

9. Americas Bleeding Disorders Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bleeding Disorders Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Bleeding Disorders Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Alnylam Pharmaceuticals Inc.
13.2. Amgen Inc.
13.3. Baxter International Inc.
13.4. Bayer AG
13.5. Bristol-Myers Squibb Company
13.6. Compounding Pharmacies Bioverativ Inc.
13.7. Janssen Global Services, LLC
13.8. Pfizer Inc.
13.9. Sanofi S.A.
13.10. Xenetic Biosciences, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2020 (USD BILLION)
FIGURE 3. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
FIGURE 4. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 (USD BILLION)
FIGURE 5. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 6. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 7. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
FIGURE 10. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2026
FIGURE 12. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTIBRINOLYTICS, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTIBRINOLYTICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY FIBRIN SEALANT, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 23. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 25. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COMPOUNDING PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COMPOUNDING PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
FIGURE 32. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2026
FIGURE 34. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2026 (USD BILLION)
FIGURE 39. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 40. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. AUSTRALIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. CHINA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. INDIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. INDONESIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. JAPAN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. MALAYSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. PHILIPPINES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. SINGAPORE BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. SOUTH KOREA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. THAILAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. NETHERLANDS BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. QATAR BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BLEEDING DISORDERS TREATMENT MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTIBRINOLYTICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COMPOUNDING PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. AUSTRALIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. CHINA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. INDIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. INDONESIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. JAPAN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. MALAYSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. PHILIPPINES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. SINGAPORE BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. SOUTH KOREA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. THAILAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. NETHERLANDS BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. QATAR BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: SCORES
TABLE 48. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: BUSINESS STRATEGY
TABLE 49. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 50. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: RANKING
TABLE 51. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 52. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: MERGER & ACQUISITION
TABLE 53. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 54. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 55. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 56. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 57. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Alnylam Pharmaceuticals Inc.
  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Compounding Pharmacies Bioverativ Inc.
  • Janssen Global Services, LLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Xenetic Biosciences, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll